Home › NDC Lookup › Ingredients › Terbinafine Hydrochloride › 51672-2080-02
Terbinafine Hydrochloride 1 g/100g Cream — NDC 51672-2080-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Terbinafine Hydrochloride 1 g/100g Cream — NDC 51672-2080-2 (Billing 51672-2080-02)

by Sun Pharmaceutical Industries, Inc. · 1 TUBE in 1 CARTON / 30 g in 1 TUBE

This is a package of Terbinafine Hydrochloride 1 g/100g Cream from Sun Pharmaceutical Industries, Inc., marketed since Jul 2007 and currently FDA-listed; retail pharmacies pay about $0.3085 per g (NADAC). It is the main listing for this product, which comes in 7 package sizes.

NDC 51672-2080-02
🏷️ FDA NDC (as labeled) 51672-2080-2 billing pads the package segment with a zero
This package
Contains30 g in 1 tube Cost per g$0.3085 NADAC Per package$9.26 / 30 g Pack sizes7 compare ↓
Also priced by: Medicaid pays $0.5120/unit — full pricing hub ↓
Main listing for product 51672-2080 · Also comes in: 15 g 51672-2080-1 60 g 51672-2080-3 15 g 51672-2080-4 45 g 51672-2080-6 12 g 51672-2080-8 24 g 51672-2080-9
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 51672-2080-2 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
51672 labeler · 2080 product · 2 package
Package marketed since
Jul 2, 2007
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 5167220802 8
Medicaid fills, this package
49,257 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 51672-2080-2
Product NDC 51672-2080
11-digit billing NDC 51672208002
NCPDP billing unit GM — per gram (weight)
RxCUI 992528
UNII 012C11ZU6G
Application # ANDA077511
SPL Set ID 92b31fc4-0f02-4857-b11f-49b9f942ee84
Established class (EPC) Allylamine Antifungal
Chemical class Allylamine
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2007-07-02
Route TOPICAL
Dosage form CREAM
Substance TERBINAFINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90150087103710
GPI class Terbinafine HCl
GCN Seq No 018273
GCN 62498
HICL code 007590
Ingredient (HICL) Terbinafine Hcl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5F
Therapeutic class — specific (HIC3) Topical Antifungals
AHFS code 08:14.04.00
AHFS class Allylamine Antifungals
FDB label name TERBINAFINE 1% CREAM
FDB brand name Terbinafine
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 018273
  • GCN: 62498
  • GPI-14 (Medi-Span): 90150087103710
  • HICL (First Databank): 007590
  • AHFS class code: 08:14.04.00
  • RxCUI (RxNorm): 992528
Why two NDCs? The FDA registers this code as 51672-2080-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 51672-2080-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Allylamine Antifungal class.

Pharmacologic class Allylamine Antifungal
Drug family (ATC) Other antifungals for topical use, Antifungals for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name TERBINAFINE 1% CREAM Ingredient Terbinafine Hcl
📗 Our plain-language guide HelloPharmacist
  • It depends on the form. The tablets treat fungal infections of the toenails or fingernails. Topical products like Lamisil AT treat athlete’s foot, jock itch and ringworm. Your doct...
  • You take one tablet by mouth once a day, with or without food. Fingernails take a shorter course than toenails. Your nail can look better only after healthy nail grows out, which t...
  • Liver failure has happened with terbinafine tablets, even in people with no liver problems. A blood test before and during treatment helps catch trouble early. Call your doctor rig...
  • Headache, diarrhea, rash, upset stomach and itching are the common ones, and they are usually mild. Call your doctor for taste or smell changes, low mood, blistering or spreading r...
📖 Read our full Terbinafine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.309 $9.26 / 30 g
Medicaid paysCMS SDUD · 12 mo $0.5120 $15.36 / 30 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.319 $0.266
▲ Up 8% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
51672-2080-01 51672-2080-1 1 TUBE in 1 CARTON / 15 g in 1 TUBE $0.3983 / g $5.97 2007-07-02 — Active
51672-2080-02 You're viewing this Main listing 1 TUBE in 1 CARTON / 30 g in 1 TUBE $0.3085 / g $9.26 2007-07-02 — Active
51672-2080-03 51672-2080-3 1 TUBE in 1 CARTON / 60 g in 1 TUBE — — 2007-07-02 — Active
51672-2080-04 51672-2080-4 1 TUBE in 1 CARTON / 15 g in 1 TUBE — — 2017-04-24 — Active
51672-2080-06 51672-2080-6 1 TUBE in 1 CARTON / 45 g in 1 TUBE — — 2007-07-02 — Active
51672-2080-08 51672-2080-8 1 TUBE in 1 CARTON / 12 g in 1 TUBE — — 2007-07-02 — Active
51672-2080-09 51672-2080-9 1 TUBE in 1 CARTON / 24 g in 1 TUBE — — 2007-07-02 — Active

This pack has the lowest per-g cost of the 2 priced pack sizes ($0.3085 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 73% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 tube in 1 carton / 30 g in 1 tube.
What NDC number is used to bill for this package of Terbinafine Hydrochloride 1 g/100g Cream?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Pharmacy 1 g/100g 24385-0524-03 AmerisourceBergen 1 tube $0.231 — Availability likely save 25%
Terbinafine Hydrochloride 1 g/100gthis 51672-2080-02 Sun 1 tube $0.309 — Availability likely —
Terbinafine Hydrochloride 1 g/100g 70677-1003-01 STRATEGIC 1 tube $0.309 — Availability likely —
Terbinafine Hydrochloride 1 g/100g 70000-0338-01 Cardinal 1 tube $0.398 — Availability likely +29%
Walgreens Athletes Foot 1 g/100g 00363-2080-01 Walgreen 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 00363-4502-02 WALGREEN 1 tube — — FDA listed —
Athletes Foot 1 g/100g 11822-0080-01 Rite 1 tube — — FDA listed —
Kroger Antifungal 1 g/100g 30142-0080-01 Kroger 1 tube — — FDA listed —
Athletes Foot 1 g/100g 37808-0080-01 H 1 tube — — FDA listed —
Antifungal 1 g/100g 41250-0080-02 Meijer 1 tube — — FDA listed —
equate Athletes Foot 1 g/100g 49035-0080-03 Wal-Mart 1 tube — — FDA listed —
Silka Antifungal 1 g/100g 50066-0080-02 Genomma 1 tube — — FDA listed —
Silka Jock Itch 1 g/100g 50066-0208-05 Genomma 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 50090-1278-00 A-S 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 50090-5810-00 A-S 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 51672-2140-01 Sun 1 tube — — FDA listed —
Athletes Foot 1 g/100g 56062-0080-02 Publix 1 tube — — FDA listed —
CVS Pharmacy Athletes Foot 1 g/100g 59779-0080-01 CVS 1 tube — — FDA listed —
Cvs 1 g/100g 59779-0523-01 CVS 1 tube — — FDA listed —
Lamisil AT Cream 1 g/100g 61047-0120-01 Voyant 1 tube — — Discontinued —
Lamisil At Terbinafine Hydrochloride 1 g/100g 61047-0139-01 Voyant 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 63187-0111-15 Proficient 1 tube — — FDA listed —
Good Neighbor Pharmacy 1 g/100g 68788-4044-01 Preferred 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 68788-9814-01 Preferred 15 g — — FDA listed —
Curist Antifungal Relief 1 g/100g 72559-0035-58 Little 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 73469-7215-02 Scholl's 1 tube — — FDA listed —
PHARMBANNER TINEA VERSICOLOR Cream 1 g/100g 83818-0024-01 Shenzhen 60 g — — FDA listed —
Lamisil AT Cream 1 g/100g 84485-3607-01 Karo 1 tube — — FDA listed —
Lamisil AT Cream 1 g/100g 84485-3748-03 Karo 1 tube — — FDA listed —
Lamisil AT Cream 1 g/100g 84485-4030-01 Karo 1 tube — — FDA listed —
Athlete Foot Cream 1 g/100g 85398-0006-01 Beautivity 60 g — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2007
On the market since
Jul 2007
📍
2026
Currently FDA-listed
19 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Terbinafine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII LKG8494WBH
    Benzyl alcohol is a clear liquid used as a preservative and solvent in medicines. It helps prevent bacterial and fungal growth and dissolves other ingredients to create uniform liquid formulations.
  • UNII 936JST6JCN
    Cetyl alcohol is a waxy, fatty substance derived from plant or animal sources. It acts as an emulsifier and thickener in medicines, helping blend oil and water components and giving products a smooth, creamy texture.
  • UNII 5ZA2S6B08X
    Cetyl palmitate is a waxy substance made from natural fats. It works as a binder and thickener to help hold the medicine together and control how it dissolves in your body.
  • UNII 0RE8K4LNJS
    Isopropyl myristate is an oily liquid made from coconut or palm oil. It's used in medicines as an emollient and penetration enhancer to help the medicine absorb through skin or improve spreadability in topical products.
  • UNII CAL22UVI4M
    A synthetic emulsifier derived from sorbitol and fatty acids. It helps mix oil and water-based ingredients together and improves the texture and stability of the medicine.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII NVZ4I0H58X
    A waxy substance made from sorbitol and stearic acid. It acts as an emulsifier and stabilizer, helping keep oil and water mixed together and preventing separation in the medicine.
  • UNII 2KR89I4H1Y
    Stearyl alcohol is a waxy, fatty substance derived from natural oils or made synthetically. It acts as an emulsifier and thickener in medicines, helping mix ingredients together and give the product the right texture.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSun Pharmaceutical Industries, Inc.
Application holderSUN PHARMA CANADA INC
FDA applicationANDA077511 (ANDA)
Labeler code51672
First marketedJul 2007
Product typeHuman Otc Drug
Portfolio890 products on file

More NDCs from Sun Pharmaceutical Industries, Inc. labeler code 51672

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 27 words ▾

Uses cures most athlete's foot (tinea pedis) cures most jock itch (tinea cruris) and ringworm (tinea corporis) relieves itching, burning, cracking and scaling which accompany these conditions

⏱️ Dosage and Administration 144 words ▾

Directions adults and children 12 years and over: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily. between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor wash hands after each use children under 12 years: ask a doctor 1 week between the toes 2 weeks on the bottom or sides of the foot Image Image

⚠️ Warnings 73 words ▾

Warnings For external use only Do not use on nails or scalp in or near the mouth or eyes for vaginal yeast infections When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water. Stop use and ask a doctor if too much irritation occurs or gets worse Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 40 words ▾

Other information TAMPER EVIDENT: DO NOT USE IF THE SEAL ON THE TUBE IS PUNCTURED OR NOT VISIBLE. store at controlled room temperature 20° to 25°C (68° to 77°F) see carton or tube crimp for lot number and expiration date

🧪 Active Ingredient 5 words ▾

Active ingredient Terbinafine hydrochloride 1%

🧪 Inactive Ingredients 20 words ▾

Inactive ingredients benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol

🎯 Purpose 2 words ▾

Purpose Antifungal

📄 Do Not Use 18 words ▾

Do not use on nails or scalp in or near the mouth or eyes for vaginal yeast infections

📄 When Using This Product 17 words ▾

When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water.

📄 Stop Use and Ask a Doctor If 14 words ▾

Stop use and ask a doctor if too much irritation occurs or gets worse

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 3 words ▾

Questions? call 1-866-923-4914

📄 Package Label / Principal Display Panel 44 words ▾

PRINCIPAL DISPLAY PANEL - 30 g Tube Carton NDC 51672-2080-2 Full Prescription Strength FOR ATHLETE'S FOOT Terbinafine Hydrochloride Cream 1% Antifungal NET WT 1 oz (30 g) Principal Display Panel - 30 g Tube Carton

PRINCIPAL DISPLAY PANEL - 30 g Tube Carton Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
49.3K
Units reimbursed last 4 qtrs
1.7M
Gross reimbursed last 4 qtrs
$850.5K
Avg / prescription
$17.27
Avg / unit
$0.5120
Latest quarter Q1 2026
10.7KRx
Medicaid pays / g
$0.5120
gross reimbursed
vs
NADAC / g
$0.3085
acquisition cost
=
Spread
+$0.2035
+66% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
43% FFS 57% MCO
Fee-for-service · 21,228 Rx Managed care · 28,029 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: 5,780 units · 294 per 100k residents ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 72,486 units · 1,263 per 100k residents MN Wisconsin: no data reported WI Michigan: 80,570 units · 803 per 100k residents MI New York: 519,677 units · 2,655 per 100k residents NY Vermont: 5,865 units · 906 per 100k residents VT New Hampshire: 2,430 units · 173 per 100k residents NH Oregon: 51,356 units · 1,213 per 100k residents OR Nevada: 20,784 units · 651 per 100k residents NV Wyoming: 390 units · 66.8 per 100k residents WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 46,561 units · 371 per 100k residents IL Indiana: 43,734 units · 637 per 100k residents IN Ohio: 102,256 units · 868 per 100k residents OH Pennsylvania: 122,237 units · 943 per 100k residents PA New Jersey: 41,675 units · 449 per 100k residents NJ Massachusetts: 36,072 units · 515 per 100k residents MA California: 39,135 units · 100 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 18,300 units · 925 per 100k residents NE Missouri: 52,667 units · 850 per 100k residents MO Kentucky: 56,414 units · 1,246 per 100k residents KY West Virginia: no data reported WV Virginia: 34,885 units · 400 per 100k residents VA Maryland: 15,193 units · 246 per 100k residents MD Connecticut: no data reported CT Rhode Island: 10,920 units · 997 per 100k residents RI Arizona: 51,195 units · 689 per 100k residents AZ New Mexico: 13,485 units · 638 per 100k residents NM Kansas: 12,090 units · 411 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 12,478 units · 232 per 100k residents SC Delaware: 3,630 units · 352 per 100k residents DE Oklahoma: 7,245 units · 179 per 100k residents OK Louisiana: 360 units · 7.9 per 100k residents LA Mississippi: 11,503 units · 391 per 100k residents MS Alabama: no data reported AL Georgia: 9,823 units · 89.1 per 100k residents GA D.C.: no data reported DC Hawaii: 1,365 units · 95.1 per 100k residents HI Texas: 158,455 units · 519 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
7.92,655
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 2,655 /100k
2 Minnesota 1,263 /100k
3 Kentucky 1,246 /100k
4 Oregon 1,213 /100k
5 Rhode Island 997 /100k
6 Pennsylvania 943 /100k
7 Nebraska 925 /100k
8 Vermont 906 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 tube this page51672-2080-02 49,257 Rx · $850,473
1 tube51672-2080-01 18,380 Rx · $238,767
1 tube51672-2080-03 No Medicaid data
1 tube51672-2080-04 No Medicaid data
1 tube51672-2080-06 No Medicaid data
1 tube51672-2080-08 No Medicaid data
1 tube51672-2080-09 No Medicaid data
Drug total (last 4 qtrs): 67,637 Rx · 2,099,599 units · $1,089,239 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Terbinafine Hydrochloride — the ingredient across all brands.

Top reported reactions

Rash498
Pruritus420
Fatigue396
Nausea383
Pain349
Ageusia325
Headache306

Age at onset

Neonate3
Infant2
Child15
Adolescent19
Adult726
Elderly421

Reporter sex

8,840 reports
Male · 48%
Female · 52%
Unknown · 0%

Serious outcomes

Hospitalization2,349
Death532
Disabling451
Life-threatening366
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 893 311
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 51672-2075-01 · Sun 51672-2085-01 · Taro →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.